To address this issue, a team from Massachusetts General Hospital, Boston, MA, has developed a novel cannula delivery system that enables the effective administration of imaging agents and compounds ...

Optiscan CEO Dr. Camile Farah delves into the company’s technology and capabilities that have positioned it as a leader ...

Photoacoustic imaging (PAI ... the latest advances in exogenous contrast agents for molecular PAI. We introduce the considerations for in vivo molecular PAI; detail the physical, chemical and ...

There is therefore an urgent need for in vivo ... the imaging of isolates within cells, is termed ‘MRI microscopy’. The resolution is about 1 μm and in combination with contrast agents ...

The characteristic properties of each distinct type of nanoparticle influence pharamacokinetics and demonstrate that size is not the only determinant of in vivo behavior. Next, we discuss current ...

The Mobile HomeCage™ is compact – it fits into most imaging set-ups without the need for modifications. Last but not least, it allows combining state-of-the-art neurophysiological techniques (such as ...

Molecular imaging, defined as the in vivo characterization of biological processes at the ... the development of bio-marker targeted fluorescence imaging agents to aid in visualization of cancer ...

The researchers say the imaging-guided deep tissue in vivo sound printing (DISP) platform utilizes low-temperature–sensitive liposomes (LTSLs) as carriers for cross-linking agents, enabling ...

Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer ...

Gozellix® is a novel product which provides a longer shelf life of up to six hours and an extended distribution radius compared to existing gallium-based imaging products. The ability to reliably ...

A research team has demonstrated in-vivo imaging of fine neuronal structures in mouse cortex through the intact skull at an unprecedented depth of 750 µm below pia, making high-resolution ...

Kevin Richardson, Chief Executive Officer, Telix Precision Medicine, said, “Securing FDA approval for Gozellix is a major win for prostate cancer patients, who gain enhanced access to state-of ...